Healthtech company Innovaccer has completed an employee stock ownership plan (ESOP) buyback worth ₹600 crore (around $75 million), providing liquidity to current and former employees holding vested stock options.
According to a media report, the buyback benefited an undisclosed number of employees holding restricted stock units (RSUs), marking one of the larger ESOP liquidity events in India’s SaaS and healthtech space this year.
The ESOP buyback follows Innovaccer’s $275 million Series F funding round, which comprised both primary and secondary capital. The round saw participation from marquee investors including B Capital, Kaiser Permanente, and Generation Investment Management, strengthening the company’s balance sheet and offering partial exits to existing stakeholders.
Founded in 2014 by Abhinav Shashank, Innovaccer operates a healthcare data and analytics platform that helps hospitals, health systems, and insurers unify clinical, financial, and operational data. The company has built a strong footprint in the US healthcare market, working closely with provider networks and payers to improve care coordination and outcomes.
On the financial front, Innovaccer reported operating revenue of ₹387.71 crore for the fiscal year ended March 2025. The company also turned profitable during the year, posting a net profit of ₹36.1 crore, reflecting improved operating efficiency and scale.
Over the past year, Innovaccer has continued to expand its capabilities through acquisitions. It acquired healthcare engagement platform Cured and Pharmacy Quality Solutions, a firm focused on medication safety and quality, to deepen its product offerings and strengthen its position across the healthcare value chain.
The ESOP buyback comes at a time when liquidity events across the startup ecosystem have remained relatively subdued. In 2025, total ESOP buyback activity stood at just over $75 million, significantly lower than $190 million in 2024 and sharply below the peaks of $802 million in 2023 and $440 million in 2021.
Innovaccer’s buyback underscores growing maturity among late stage SaaS companies, as they balance growth, profitability, and employee wealth creation.
Follow Startupbydoc for daily startup insights, funding news, IPO analysis, and business breakdowns.